Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.
Roosan MR, Mambetsariev I, Pharaon R, Fricke J, Baroz AR, Chao J, Chen C, Nasser MW, Chirravuri-Venkata R, Jain M, Smith L, Yost SE, Reckamp KL, Pillai R, Arvanitis L, Afkhami M, Wang EW, Chung V, Cristea M, Fakih M, Koczywas M, Massarelli E, Mortimer J, Yuan Y, Batra SK, Pal S, Salgia R. Roosan MR, et al. Among authors: salgia r. Cancers (Basel). 2021 Jun 3;13(11):2776. doi: 10.3390/cancers13112776. Cancers (Basel). 2021. PMID: 34204917 Free PMC article.
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Lara PN Jr, Longmate J, Mack PC, Kelly K, Socinski MA, Salgia R, Gitlitz B, Li T, Koczywas M, Reckamp KL, Gandara DR. Lara PN Jr, et al. Among authors: salgia r. Clin Cancer Res. 2015 Oct 1;21(19):4321-6. doi: 10.1158/1078-0432.CCR-14-3281. Epub 2015 Jun 23. Clin Cancer Res. 2015. PMID: 26106072 Free PMC article.
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Carter CA, Rajan A, Keen C, Szabo E, Khozin S, Thomas A, Brzezniak C, Guha U, Doyle LA, Steinberg SM, Xi L, Raffeld M, Tomita Y, Lee MJ, Lee S, Trepel JB, Reckamp KL, Koehler S, Gitlitz B, Salgia R, Gandara D, Vokes E, Giaccone G. Carter CA, et al. Among authors: salgia r. Ann Oncol. 2016 Apr;27(4):693-9. doi: 10.1093/annonc/mdw008. Epub 2016 Jan 22. Ann Oncol. 2016. PMID: 26802155 Free PMC article.
FAK and paxillin, two potential targets in pancreatic cancer.
Kanteti R, Batra SK, Lennon FE, Salgia R. Kanteti R, et al. Among authors: salgia r. Oncotarget. 2016 May 24;7(21):31586-601. doi: 10.18632/oncotarget.8040. Oncotarget. 2016. PMID: 26980710 Free PMC article. Review.
Value-Based Medicine and Integration of Tumor Biology.
Brooks GA, Bosserman LD, Mambetsariev I, Salgia R. Brooks GA, et al. Among authors: salgia r. Am Soc Clin Oncol Educ Book. 2017;37:833-840. doi: 10.1200/EDBK_175519. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561700 Free article. Review.
606 results